First Citizens Bank & Trust Co. Buys 25,781 Shares of Henry Schein, Inc. $HSIC

Key Points

• First Citizens Bank & Trust Co. increased its stake in Henry Schein, Inc. by 36.5% during the second quarter, owning a total of 96,475 shares valued at approximately $7.05 million.
• Recent analyst reports have given mixed ratings on Henry Schein, with target prices ranging from $72.00 to $83.00 and an average target price of $76.67 among analysts.
• Henry Schein reported a net margin of 3.05% and earnings of $1.10 per share for the last quarter, falling short of analyst expectations of $1.19 per share.

First Citizens Bank & Trust Co. lifted its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 36.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 96,475 shares of the company's stock after acquiring an additional 25,781 shares during the quarter. First Citizens Bank & Trust Co. owned 0.08% of Henry Schein worth $7,047,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Steph & Co. purchased a new stake in Henry Schein during the 2nd quarter valued at $44,000. CX Institutional boosted its position in shares of Henry Schein by 107.3% in the second quarter. CX Institutional now owns 651 shares of the company's stock worth $48,000 after purchasing an additional 337 shares during the period. TD Private Client Wealth LLC increased its stake in shares of Henry Schein by 103.0% in the second quarter. TD Private Client Wealth LLC now owns 668 shares of the company's stock worth $49,000 after purchasing an additional 339 shares in the last quarter. Whittier Trust Co. raised its position in shares of Henry Schein by 714.3% during the 1st quarter. Whittier Trust Co. now owns 798 shares of the company's stock valued at $55,000 after purchasing an additional 700 shares during the period. Finally, Quarry LP purchased a new position in shares of Henry Schein during the 1st quarter valued at $71,000. Institutional investors own 96.62% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. JPMorgan Chase & Co. decreased their target price on Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a research note on Thursday, August 7th. Leerink Partners set a $75.00 target price on shares of Henry Schein in a research note on Monday, July 14th. Baird R W lowered shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Robert W. Baird reaffirmed a "neutral" rating and set a $72.00 target price (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Finally, Evercore ISI upgraded Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price objective for the company in a report on Tuesday, August 26th. Five research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat, Henry Schein currently has an average rating of "Hold" and an average target price of $76.67.

Henry Schein Stock Down 1.9%

Henry Schein stock opened at $63.00 on Thursday. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The business has a fifty day moving average of $66.90 and a two-hundred day moving average of $68.53. The firm has a market cap of $7.64 billion, a P/E ratio of 20.32, a P/E/G ratio of 2.12 and a beta of 0.81. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). The company had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. Henry Schein's revenue for the quarter was up 3.3% compared to the same quarter last year. During the same period in the previous year, the business earned $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.